Schrödinger can earn more from the partnership if milestones are reached. The new programs replace the old ones, but the report gives no sign that this change lowers the possible payments.
The higher possible payment gives Schrödinger a larger chance to earn money from the partnership. The companies also replaced the prior programs, but the report gives no result showing this change weakens that opportunity.
Novartis switched to 2 new programs and may owe Schrödinger more if milestones are reached. The report gives no expected research results or sales change, so it does not show a clear change in Novartis's outlook.
Follow Schrödinger, Inc. (SDGR) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for SDGR